Search Options Stock News and Analysis from Schaeffer's

BREAKING NEWS: Stocks Struggle for Direction Amid Earnings, Housing Data

About Us
Market News
Premium
Options 101
Deals
Log-In
Search

>> Author and trader Adam Warner stops by our latest Market Mashup podcast to discuss the recent VIX spike and how to respond as a trader. <<

content-search-index Tag: AXSM AXSM 5 SEARCH RESULTS FOR: "Tag: AXSM"

REFINE YOUR SEARCH

REFINE YOUR SEARCH:

ARTICLES/BLOGS

2019(4)

2018(1)

CATEGORIES

Analyst Update(3)

Buzz Stocks(2)

Intraday Option Activity(1)

Stocks On the Move(1)

Analyst: This Surging Drug Stock Could Double

https://www.schaeffersresearch.com/content/news/2019/12/17/analyst-this-surging-drug-stock-could-double

12/17/2019 1:44 PM

Axsome Therapeutics Inc (NASDAQ:AXSM) stock surged more than 70% yesterday after the company said its major depressive disorder drug succeeded in a late-stage study, and it plans on filing for a marke...

Analyst: This White-Hot Pharma Stock Could Double

https://www.schaeffersresearch.com/content/news/2019/05/28/analyst-this-white-hot-pharma-stock-could-double

5/28/2019 11:11 AM

Axsome Therapeutics Inc (NASDAQ:AXSM) presented data on AXS-05 at the American Psychiatric Association (APA) conference this weekend, and analysts are rewarding the equity today. Cantor Fitzgerald h...

2 Red-Hot Drug Stocks Squeezing Shorts

https://www.schaeffersresearch.com/content/news/2019/05/06/2-red-hot-drug-stocks-squeezing-shorts

5/6/2019 9:55 AM

Near the top of the Nasdaq today sits Esperion Therapeutics Inc (NASDAQ:ESPR), after the Food and Drug Administration (FDA) accepted marketing applications for the company's cholesterol drug. At last...

Penny Stock Doubles on Depression Drug Data

https://www.schaeffersresearch.com/content/news/2019/01/07/penny-stock-doubles-on-depression-drug-data

1/7/2019 9:57 AM

The shares of penny stock Axsome Therapeutics Inc (NASDAQ:AXSM) are up a whopping 164.4% at $6.95 in early trading, after the company's experimental depression drug, AXS-05, realized its main goal in...

Drugmaker Jumps on FDA Decision; Caesars In M&A Spotlight

https://www.schaeffersresearch.com/content/news/2018/10/17/drugmaker-jumps-on-fda-decision-caesars-in-m-a-spotlight

10/17/2018 2:51 PM

Stocks are trading lower today, pulling back some from yesterday's impressive rally. Meanwhile, casino concern Caesars Entertainment Corporation (NASDAQ:CZR) and biopharma name Axsome Therapeutics ...

PEOPLE ALSO SEARCH FOR